Research programme: parathyroid hormone analogues - Xsira Pharmaceuticals
Alternative Names: Non-desensitising parathyroid hormone analogues; Non-desensitising PTH analogues; Parathyroid hormone analogues - Xsira; PTH analogues - Xsira; PTH-NDLLatest Information Update: 16 Jul 2016
Price :
$50 *
At a glance
- Originator Xsira Pharmaceuticals
- Class
- Mechanism of Action G protein-coupled receptor agonists; Signal transduction pathway modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Osteoporosis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Osteoporosis in USA
- 19 Jul 2006 Preclinical trials in Osteoporosis in USA (unspecified route)